The Feasibility of LVHIIT on Inpatient Stroke Rehab
The Feasibility of Low-Volume High Intensity Interval Training on Inpatient Stroke Rehab
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
The objective of this study is to explore the safety and feasibility of conducting low-volume, high-intensity interval training (HIIT) on a total body recumbent stepper (TBRS) in persons with stroke in an inpatient rehabilitation setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1 stroke
Started Apr 2026
Shorter than P25 for early_phase_1 stroke
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedStudy Start
First participant enrolled
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 15, 2026
April 1, 2026
3 months
March 5, 2025
April 10, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Safety of LVHIIT (low volume high intensity interval training) on total body recumbent stepper
Treatment related adverse events will be defined as the presence of study-related cardiac or serious adverse events. The Investigators hypothesize that low-volume, short-interval, TBRS HIIT will have no incidents of treatment related adverse events in participants with subacute stroke while admitted to inpatient rehabilitation during HIIT (H1a) and within the 30 minutes following HIIT cessation (H1b).
2-3 months
Adherence of LVHIIT (low volume high intensity interval training) on total body recumbent stepper
Feasibility will be assessed by adherence to the exercise session, attainment of target heart rates, and acceptability of the exercise. Adherence will measured by ≥ 75% of participants complete the entire 10-minute HIIT bout (H2a). Units will be the number of participants that are able to finish the full 10 minute bout of exercise.
2-3 months
Attainment of LVHIIT (low volume high intensity interval training) on total body recumbent stepper
Feasibility will be assessed by adherence to the exercise session, attainment of target heart rates, and acceptability of the exercise. Attainment will be measured by ≥75% of participants will reach target heart rates (75%-85% max HR) during ≥75% of the high-intensity intervals (H2b). Heart rates will be measured in beats per minute. HR max will be calculated using an algorithm that adjusts for age, or beta blocker use. Units will be the number of participants reaching target HR.
2-3 months
Acceptability of LVHIIT (low volume high intensity interval training) on total body recumbent stepper
Feasibility will be assessed by adherence to the exercise session, attainment of target heart rates, and acceptability of the exercise. To examine acceptability, the valid and reliable 8-item Physical Activity Enjoyment Scale (PACES-8) will be used, where higher scores indicate greater exercise enjoyment (H2c).
2-3 months
Study Arms (1)
Low-Volume High Intensity Interval Training
EXPERIMENTALThis is the only arm in the study as it is a feasibility trial.
Interventions
Participants will conduct aerobic exercise on a total body recumbent stepper to get their heart rates to levels consistent with high intensity exercise.
Eligibility Criteria
You may qualify if:
- Both sexes between the age of 18-85 years at time of consent
- Ischemic or hemorrhagic stroke at consent. People with stroke and newly diagnosed cardiovascular complications had \>50% prevalence of recurrent stroke at 5 years. Index stroke or recurrent stroke on same side as index stroke will be allowed.
- Exercise continuously for minimum of 30 watts for 3 minutes on the recumbent stepper to demonstrate ability to perform the exercise test or therapist confirmation/documentation of participant's ability to use the recumbent stepper.
- No aerobic exercise contraindications or other safety/physical concerns during the submaximal exercise test determined by the therapy team or inpatient physicians.
- Able to communicate with investigators, follow 2-step command \& correctly answer consent comprehension questions
You may not qualify if:
- Implanted pacemaker or defibrillator limiting exercise performance
- Reported pain that limits or interferes with activities of daily living and physical activity/exercise
- Acute Myocardial Infarction in the last 2 days
- Ongoing unstable Angina
- Active Endocarditis
- Symptomatic Severe Aortic Stenosis
- Decompensated Heart Failure
- Acute Pulmonary Embolism, Pulmonary Insufficiency, or Deep Veinous Thrombosis
- Acute Myocarditis or Pericarditis
- Other significant neurologic, orthopedic, or peripheral vascular conditions that would limit exercise participation
- Oxygen-dependent chronic obstructive pulmonary disease
- Neurological disease (Multiple Sclerosis, Alzheimer's disease, Parkinson's disease)
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra Arickx, MD
University of Kansas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2025
First Posted
May 31, 2025
Study Start
April 13, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04